Natural history of non-functioning pituitary neuroendocrine tumours: impact of baseline characteristics and gender-specific clinical presentations [0.03%]
无功能垂体神经内分泌肿瘤的自然史：基线特征和性别特异性临床表现的影响
Alessandro Bavaresco,Giulia Bovo,Alessandro Mondin et al.
Alessandro Bavaresco et al.
Background: Non-functioning pituitary neuroendocrine tumours (NF-PitNETs) are the most common pituitary macroadenomas, with highly variable clinical behaviour. Although tumor growth and functional impairment are key consi...
Temozolomide in aggressive and metastatic pituitary tumors: a Brazilian multicenter real-world cohort study [0.03%]
托莫西朵姆昔在侵袭性垂体肿瘤和转移性垂体肿瘤中的应用：一项巴西多中心真实世界队列研究
Isabelle Pinheiro Amaro de Magalhães,Camila Regina Pereira Batista de Macedo,Luciana Ansaneli Naves et al.
Isabelle Pinheiro Amaro de Magalhães et al.
Purpose: To evaluate the real-world efficacy and safety of temozolomide (TMZ) in aggressive and metastatic pituitary neuroendocrine tumors in a Latin American setting, and to address whether TMZ achieves meaningful radiol...
Prolactin measurements in a real-life setting: a population-based cohort study [0.03%]
真实世界条件下的泌乳素测定：一项基于人群的队列研究
Christoffer Krogager,Jens Otto Lunde Jørgensen,Claus Højbjerg Gravholt et al.
Christoffer Krogager et al.
Purpose: Hyperprolactinemia is mainly due to pituitary disorders including prolactinomas but other causes including adverse drug reactions exist. This study aimed to assess the frequency and pattern of serum prolactin mea...
AIP expression and imaging findings in somatotroph adenomas after pre-operative lanreotide therapy for acromegaly [0.03%]
长效奥曲肽治疗肢端肥大症术前后的生长激素指数和影像学变化
Ellie Edlmann,Muhammad Shahzad,Jason Yuen et al.
Ellie Edlmann et al.
Age and hematologic parameters can predict prolonged glucocorticoid replacement after remission of cushing disease and adrenal Cushing's syndrome: A nationwide cohort study [0.03%]
年龄和血常规指标可以预测库欣病和肾上腺库欣综合征缓解后的长期糖皮质激素替代治疗：一项全国队列研究
Nidhi Agrawal,Shruti N Shah,Shiri Kushnir et al.
Nidhi Agrawal et al.
Pregnancy and delivery after surgical remission in women with prolactinomas desiring pregnancy: Refining surgical indications [0.03%]
手术治愈的泌乳素瘤患者的妊娠与分娩：细化手术指征
Kosaku Amano,Yasufumi Seki,Yuichi Oda et al.
Kosaku Amano et al.
Objective: Prolactinomas are usually managed with cabergoline, and surgery is reserved for strictly selected cases. Based on our surgical experience, we observed no recurrence in women who conceived and delivered after su...
Absence of detectable circadian rhythmicity of neurophysin I, a surrogate marker for oxytocin [0.03%]
未检测到神经生理蛋白I的可检测的昼夜节律性，这是一种催产素的替代标记物
Cihan Atila,Rakithan Murugesu,Deborah Rudin et al.
Cihan Atila et al.
Efficacy and safety of once-weekly somatrogon in adults with growth hormone deficiency: a randomized phase 3 study [0.03%]
成人生长激素缺乏症的一周一次somatrogon疗效和安全性：一项三期随机临床试验
Maria Fleseriu,Beverly M K Biller,Susan M Webb et al.
Maria Fleseriu et al.
Purpose: This study assessed the efficacy and safety of once-weekly somatrogon, a long-acting growth hormone, in adults with growth hormone deficiency (aGHD). ...
Correction: Patients with Langerhans cell histiocytosis and hypothalamic-pituitary involvement: insights from the HEROS study cohort [0.03%]
Langerhans细胞组织细胞增生症伴下丘脑-垂体受累患者的HEROS研究队列分析：一项更正报告
Hiba Masri Iraqi,Marina Tsoli,Mattia Barbot et al.
Hiba Masri Iraqi et al.
Published Erratum
Pituitary. 2026 Mar 25;29(2):57. DOI:10.1007/s11102-025-01631-z 2026
Luis V Syro,Nicolas Coronel-Restrepo,Adriana M Penagos et al.
Luis V Syro et al.